Can-Fite BioPharma annual operating margin
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Can-Fite BioPharma Operating Margin Growth & History (CANF)
Can-Fite BioPharma's operating margin was −2,456.79% for fiscal 2025.
View full Can-Fite BioPharma company overviewCan-Fite BioPharma annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −2,456.79% | −1250.56 pp |
| 2024 | 2024-12-31 | −1,206.23% | −103.27 pp |
| 2023 | 2023-12-31 | −1,102.96% | +143.46 pp |
| 2022 | 2022-12-31 | −1,246.42% | +259.09 pp |
| 2021 | 2021-12-31 | −1,505.51% | +347.57 pp |
| 2020 | 2020-12-31 | −1,853.08% | −1262.18 pp |
| 2019 | 2019-12-31 | −590.90% | −449.17 pp |
| 2018 | 2018-12-31 | −141.73% | +768.92 pp |
| 2017 | 2017-12-31 | −910.65% | +4351.78 pp |
| 2016 | 2016-12-31 | −5,262.42% | — |
Can-Fite BioPharma quarterly operating margin
No reported data
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|
Can-Fite BioPharma operating margin trends
Over the last five reported fiscal years, Can-Fite BioPharma's operating margin decreased from −1,853.08% to −2,456.79%, a change of −603.71 percentage points.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Can-Fite BioPharma filings at SEC.gov ↗